Age-related decline in muscle strength and power output in acid 1-4 α-glucosidase knockout mice

Muscle and Nerve

Volumn 31, Issue 3, 2005, Pages 374-381

  Hesselink, Reinout P ^a   Van Kranenburg, Gerrit ^a   Wagenmakers, Anton J M ^a   Van Der Vusse, Ger J ^b   Drost, Maarten R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dynamometer; GSD II; Mouse; Muscle strength; Peak power

Indexed keywords

ALPHA GLUCOSIDASE; GLYCOGEN; LYSOSOME ENZYME; MUSCLE PROTEIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; DYNAMOMETRY; ENZYME ACTIVITY; GLYCOGEN STORAGE DISEASE TYPE 2; GROUPS BY AGE; KNOCKOUT MOUSE; MOUSE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; TORQUE;

AGING; ANIMALS; GLUCAN 1,4-ALPHA-GLUCOSIDASE; GLYCOGEN; ISOMETRIC CONTRACTION; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; TORQUE;

EID: 13844320077     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20270     Document Type: Article

References (28)

1. Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999;7:713-716.
2. Bijvoet AG, Van Hirtum H, Vermey M, Van Leenen D, Van Der Ploeg AT, Mooi WJ, et al. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model. J Pathol 1999;189:416-424.
3. Bijvoet AGA, Van der Kamp EHM, Kroos MA, Ding J-H, Yang BZ, Visser P, et al. Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet 1998;7:53-62.
4. de Jonge AJ, de Smit S, Kroos MA, Reuser AJ. Cotransfer of syntenic human genes into mouse cells using isolated metaphase chromosomes or cellular DNA. Hum Genet 1985;69:32-38.
5. Drost MR, Hesselink RP, Oomens CWJ, Van der Vusse GJ. Effects of non-contractile inclusions on mechanical performance of skeletal muscle. J Biomech (in press).
6. Edwards RH, Hill DK, Jones DA. Metabolic changes associated with the slowing of relaxation in fatigued mouse muscle. J Physiol (Lond) 1975;251:287-301.
7. Fraites TJ Jr, Schleissing MR, Shanely RA, Walter GA, Cloutier DA, Zolotukhin I, et al. Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors. Mol Ther 2002;5:571-578.
8. Gambetti P, DiMauro S, Baker L. Nervous system in Pompe's disease. Ultrastructure and biochemistry. J Neuropathol Exp Neurol 1971;30:412-430.
9. Gorselink M, Drost MR, de Louw J, Willems PJ, Hesselink MK, Dekkers EC, et al. In situ assessment of shortening and lengthening contractile properties of hind limb ankle flexors in intact mice. Pflugers Arch 2001;442:304-311.
10. Gorselink M, Drost MR, de Louw J, Willems PJ, Rosielle N, Janssen JD, et al. Accurate assessment of in situ isometric contractile properties of hindlimb plantar and dorsal flexor muscle complex of intact mice. Pflugers Arch 2000;439:665-670.
11. Griffin JL. Infantile acid maltase deficiency. II. Muscle fiber hypertrophy and the ultrastructure of end-stage fibers. Virchows Arch B Cell Pathol Incl Mol Pathol 1984;45:37-50.
12. Griffin JL. Infantile acid maltase deficiency. III. Ultrastructure of metachromatic material and glycogen in muscle fibers. Virchows Arch B Cell Pathol Incl Mol Pathol 1984;45:51-61.
13. Hers HG. α-Glucosidase deficiency in generalized glycogen storage disease (Pompe's disease). Biochem J 1963;86:11-16.
14. Hesselink RP, Gorselink M, Schaart G, Wagenmakers AJ, Kamphoven J, Reuser AJ, et al. Impaired performance of skeletal muscle in alpha-glucosidase knockout mice. Muscle Nerve 2002;25:873-883.
15. Hill AV. The heat of shortening and the dynamic constants of muscle. Proc R Soc Lond B 1938;126:136-195.
16. Hirschhorn R, Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In Scriver CR et al., editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995. p 2443-2464.
17. Kikuchi T, Wen Yang H, Pennybacker M, Ichihara N, Mizutani M, Van Hove JLK, et al. Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase deficient quail. J Clin Invest 1998;101:827-833.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:165-275.
19. Martin JJ, de Barsy T, van Hoof F, Palladini G. Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol (Berl) 1973;23:229-244.
20. Newsholme EA, Leech AR. Biochemistry for the medical sciences. Chichester, UK: John Wiley & Sons; 1995.
21. Passonneau JV, Lauderdale VR. A comparison of three methods of glycogen measurement in tissues. Anal Biochem 1974; 60:405-412.
22. Pompe JC. Over idiopathische hypertrofie van het hart. Ned Tijdsch Geneesk 1932;76:304-311.
23. Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L, et al. Targeted disruption of the acid α-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease Type II. J Biol Chem 1998;273:19086-19092.
24. Raben N, Nagaraju K, Lee E, Plotz P. Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene. Neuromuscul Disord 2000;10:283-291.
25. Reuser AJJ, Kroos MA, Hermans MMP, Bijvoet AGA, Verbeet MP, Van Diggelen OP, et al. Glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995;3(suppl):S61-S69.
26. Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 2000;137:283-285.
27. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
28. van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112:332-340.